JAK Inhibitor
XJTU1AF2020LSK-193
Approved small_molecule active
Quick answer
JAK Inhibitor for Dermatomyositis, Adult Type is a Approved program (small_molecule) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- First Tracks Biotherapeutics
- Indication
- Dermatomyositis, Adult Type
- Phase
- Approved
- Modality
- small_molecule
- Status
- active